ACCESS PHARMACEUTICALS INC (ACCP) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 33 transactions totaling $1.8M, demonstrating a bearish sentiment with -$224.6K in net insider flow. The most recent transaction on Jun 29, 2012 involved a sale of 179,157 shares valued at $98.5K.
No significant insider buying has been recorded for ACCP in the recent period.
No significant insider selling has been recorded for ACCP in the recent period.
Based on recent SEC filings, insider sentiment for ACCP is bearish with an Insider Alignment Score of 44/100 and a net flow of -$224.6K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ACCESS PHARMACEUTICALS INC (ACCP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading ACCP stock, having executed 33 transactions in the past 90 days. The most active insider is Larry N. Feinberg (Executive), who has made 27 transactions totaling $1.6M.
Get notified when executives and directors at ACCP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 29, 2012 | Partners, Llc Acm Capital | Executive | Sale | 179,157 | $0.55 | $98.5K | |
| Jun 28, 2012 | Partners, Llc Acm Capital | Executive | Sale | 25,000 | $0.68 | $17.0K | |
| May 16, 2012 | Partners, Llc Acm Capital | Executive | Sale | 140,300 | $0.67 | $94.0K | |
| May 15, 2012 | Partners, Llc Acm Capital | Executive | Sale | 1,000 | $0.85 | $850 | |
| Jan 23, 2012 | P. Nowotnik David | Executive | Award | 15,000 | $1.36 | $20.4K | |
| Jan 23, 2012 | B. Thompson Stephen | Executive | Award | 15,000 | $1.36 | $20.4K | |
| Feb 12, 2008 | N. Feinberg Larry | Executive | Sale | 29,736 | $3.15 | $93.7K | |
| Feb 12, 2008 | N. Feinberg Larry | Executive | Purchase | 29,736 | $3.15 | $93.7K | |
| Jul 24, 2007 | N. Feinberg Larry | Executive | Sale | 2,040 | $4.35 | $8.9K | |
| Jul 23, 2007 | N. Feinberg Larry | Executive | Sale | 4,000 | $4.36 | $17.4K | |
| Jun 19, 2007 | N. Feinberg Larry | Executive | Purchase | 60,000 | $5.17 | $310.2K | |
| Jun 19, 2007 | N. Feinberg Larry | Executive | Sale | 20,000 | $5.17 | $103.4K | |
| Jun 19, 2007 | N. Feinberg Larry | Executive | Sale | 40,000 | $5.17 | $206.8K | |
| Mar 1, 2007 | N. Feinberg Larry | Executive | Sale | 1,200 | $7.13 | $8.6K | |
| Feb 28, 2007 | N. Feinberg Larry | Executive | Sale | 4,500 | $7.10 | $31.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 22 | $1.0M | 54.9% |
Purchase(P) | 8 | $809.5K | 43.0% |
Award(A) | 2 | $40.8K | 2.2% |
Other(J) | 1 | $0 | 0.0% |
Insider activity at ACCESS PHARMACEUTICALS INC shows mixed signals across all time. While $809.5K in purchases indicates some executive confidence,$1.0M in sales balances the picture, resulting in a modest net flow of -$224.6K.4 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Larry N. Feinberg, has transacted $1.6M during this period.